Form 4: Relay Therapeutics' Chief Legal Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Brian Adams, Chief Legal Officer of Relay Therapeutics, sold 1,623 shares of common stock on April 29, 2024, to cover income tax withholding obligations upon the vesting of restricted stock units.
Summary
- On April 29, 2024, Brian Adams, the Chief Legal Officer of Relay Therapeutics, sold 1,623 shares of the company's common stock.
- The sale was executed at a price of $6.38 per share.
- This transaction was to cover income tax withholding obligations related to the vesting of 5,505 restricted stock units (RSUs) on April 27, 2024.
- Following the transaction, Adams beneficially owns 325,767 shares of Relay Therapeutics, including 291,320 shares underlying RSUs.
- The sale was conducted in accordance with Relay Therapeutics' policies regarding the vesting of RSUs, and Adams had no discretion over the sale.
Sentiment
Score: 5
Explanation: The document reflects a neutral event (stock sale for tax obligations) with no inherent positive or negative implications for the company's overall prospects.
Industry Context
Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This transaction appears to be a standard sale to cover tax obligations related to RSU vesting, which is a common practice among executives.
Key Dates
| Date | Description |
|---|---|
| 04/27/2024 | Vesting date of 5,505 restricted stock units (RSUs) |
| 04/29/2024 | Date of stock sale by Brian Adams |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.